TIME：9:10, Apr. 23, 2026
VENUE：Room 4009, Cixi Campus, NIMTE
Abstract:
Cancer immunotherapy is rapidly maturing towards extensive clinical use. However, the clinical translation of cancer immunotherapy-based approaches is hindered by poor tumor specificity, off-target toxicity, and inadequate bioavailability, which has invigorated a fervor of investigation into nanomedicine-based approaches. Nanomedicine-based cancer immunotherapy has emerged as a promising approach to improve the therapeutic potential. The recent advances in the synergistic cancer immunotherapy will be discussed, with a focus on tumor immune microenvironment-responsive highly sophisticated supramolecular prodrugs. How the combination of nanomedicine with photoimmunotherapy, radiation therapy, and chemotherapy can broaden the impact of cancer immunotherapy will be explored. The integration of nanomedicine with potentially curative therapeutic modalities may broaden the clinical performance ofconventional approaches.
Speaker Biography:
Dr. Madiha Saeed completed her PhD in 2018 under the guidance of Professor WU Aiguo at the Ningbo Institute of Materials Technology & Engineering (NlMTE), Chinese Academy of Sciences (CAS), as a CAS-TWAS President's PhD Fellow. She then received the CAS President's International Fellowship Initiative (PIFI) Postdoctoral Fellowship from the Shanghai Institute of Materia Medica. In 2022, she joined the Interdisciplinary Research Center in Biomedical Materials (IRCBM), COMSATS University Islamabad, Lahore Campus, as an Assistant Professor. She currently leads national and international research projects on nanomedicine-based combination cancer immunotherapy, including those from the International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy, and the Pakistan Science Foundation(PSF).
She has published over thirty-five articles in peer-reviewed journals, including Advanced Materials, Advanced Functional Materials, Advanced Science, Accounts of Materials Research, Nano Today, Small, Biomaterial, Theranostics, Advanced Healthcare Materials, and Nano Letters, etc. (cumulative impact factor of approximately 500, an h-index of 29, and over 3,000 citations). She has been awarded several prestigious fellowships, awards, and research grants, including the Research Project Winner Award from COMSATS University (2025); a Letter of Appreciation from the Rector of COMSATS University for outstanding performance (2024-2025); CAS PIFI Visiting Scientist (2023-2024); recognition as High-Level Foreign Talent (Category A) by the Shanghai Administration of Foreign Experts (2023-2033); the Research Fund for International Young Scientists from the National Natural Science Foundation of China (NSFC, 2021-2022); CAS PIFI Postdoctoral Fellowship (2019-2021); the Outstanding Employee Award(2019) from the Shanghai Institute of Materia Medica; the CAS-The World Academy of Sciences (TWAS) President's Ph.D. Fellowship(2014-2018).
